NDC 65162-0228-08
Estradiol .1 mg/d PATCH, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
65162-0228-08
Generic Name
Estradiol
Brand Name
LYLLANA
Strength
.1 mg/d
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Package Size
—
Labeler
Amneal Pharmaceuticals LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE LYLLANA is indicated for: LYLLANA ® is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ) Prevention of postmenopausal osteoporosis ( 1.2 ) Limitations of Use When prescribing solely for the treatment of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis. 1.1 Treatment of Moderate to Severe Vasomotor Symptoms Due to…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Estradiol Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Estradiol NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 65162-0228-08 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).